2024 PBS post-market review framework

31 January 2024 - The 2024 post-market review framework is now available. ...

Read more →

PBAC Public Summary Document - May 2023

24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...

Read more →

Consultation on the revised PBS post-market review framework – publication of responses

20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...

Read more →

Final report for the post-market review of medicines for smoking cessation and review outcomes

22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The ...

Read more →

External consultation on the draft revised post-market review framework (deadline extension)

29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...

Read more →

Consultation on the revised PBS post-market review framework

20 October 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...

Read more →

Stakeholder consultation forum: post-market review of opiate dependence treatment program medicines

3 February 2022 - A stakeholder consultation forum for the post-market review of opiate dependence treatment program medicines will be ...

Read more →

Progress update: post-market review of medicines for smoking cessation

12 November 2021 - In June 2021, the Drug Utilisation Sub-Committee and the Economics Sub-Committee of the PBAC considered the report ...

Read more →

Final terms of reference and public consultation to the post-market review of opiate dependence treatment program medicines

17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...

Read more →

Post-market review of medicines for smoking cessation – public consultation on the draft report

7 June 2021 - The draft report for the post-market review of medicines for smoking cessation is available for public comment ...

Read more →

Post-market review of opiate dependence treatment program medicines

28 May 2021 - On 24 March 2021 it was announced the Department of Health will conduct a post-market review ...

Read more →

Post-market review of medicines available on the PBS Opiate Dependence Treatment Program

24 March 2021 - The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical ...

Read more →

Post-market review of medicines for smoking cessation – stakeholder forum outcome

15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...

Read more →

Closure of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis

21 December 2020 - A plain language summary for the post-market review of the use of biologics in the treatment ...

Read more →

Post-market review of medicines for smoking cessation – targeted stakeholder forum

9 November 2020 - A Stakeholder Forum will be held via webinar for the post-market review of medicines for smoking cessation ...

Read more →